This version is not peer-reviewed.
Submitted:
02 August 2023
Posted:
03 August 2023
You are already at the latest version
A peer-reviewed article of this preprint also exists.
Product | Mite | Test environment | Mortality* | Action | Reference |
---|---|---|---|---|---|
Neutral detergent 10%1, diatomaceous earth 10%2 | D. gallinae | Laboratory | 100%1, and 97%2 | Intoxication | [53] |
Diatomaceous earth 10%1, diatomaceous earth 10% + mechanical cleaning2 | D. gallinae | Laboratory | 93.4%1, and 90%2 | Intoxication and paralysis | [3] |
Natural diatomaceous earth | D. gallinae | Laboratory | 100% | Intoxication | [104] |
Product | Chemical class | Mite | Test environment | Mortality* | Action | Reference |
---|---|---|---|---|---|---|
Metrifonate (trichlorfon) | Organophosphate | D. gallinae | Field | 99% | Paralysis and death | [14] |
D.D.V.P (Dichlorvos) diluted in water1,D.D.V.P (Dichlorvos) diluted in oil 2, deltamethrin3, amitraz4 | Organophosphate1,organophosphate2, pyrethroid3 and formadin4 | D. gallinae, O. sylviarum | Laboratory | DL50=513.34 ppm1, DL50=314.15 ppm2, DL50=389.57 ppm3, and DL50=347.24 ppm4# | Paralysis and death | [86] |
Phoxim 50% | Organophosphate | D. gallinae | Field | 99% | Paralysis and death | [52] |
Cypermethrin and Cypermethrin1 + Chlorpyrifos2 | Pyrethroid1 and Pyrethroid2 | O. sylviarum | Laboratory | > 95% | Paralysis and death | [100] |
Fluralaner | Isoxazoline | D. gallinae | Laboratory | 100% | Paralysis and death | [11] |
Fluralaner1, Spinosad2, Phoxim3, Propoxur4, Permethrin5 and Deltamethrin6 | Isoxazoline1, Macrocyclic lactone2, Organophosphate3, Carbamate4, Pyrethroid5 and Pyrethroid6 | O. sylviarum | Laboratory | 100%1, 98% 2, 100%3, 100%4, 12%5, and 14%6 | Paralysis and death | [58] |
Fluralaner | Isoxazoline | O. sylviarum | Laboratory | >90% | Paralysis and death | [35] |
Fluralaner | Isoxazoline | D. gallinae | Field1 and laboratory2 | 190,6%, and 2100% | Paralysis and death | [101] |
Phoxim | Organophosphate | D. gallinae | Field1 and laboratory2 | 100%1, and 100%2 | Paralysis and death | [101] |
Cypermethrin | Pyrethroid | D. gallinae | 1Field | 15.6% | Paralysis and death | [101] |
Moxidectin1, ivermectin2 and eprinomectin3 | Macrocyclic lactone | D. gallinae | Laboratory | 45.60%1, 71.32%2, and 100%3 | Paralysis and death | [110] |
Cypermethrin + Chlorpyrifos + Piperonyl Butoxide1, Alkyl Benzyl Dimethyl Ammonium, Chloride + Glutaraldehyde + Deltamethrin2, Dichlorvos3, and Fluralaner4 | Pyrethroid + organophosphosphateus1 + organic compound, pyrethroid2, organophospha te3 and isoxazoline4 | D. gallinae | Laboratory | 197.5%, 2100%, 3100%, and 4100% | Paralysis and death | [94] |
Product | Mite | Type of assay | Mortality (M)/Repellency (R) | Action | Reference |
---|---|---|---|---|---|
Coffea aqueous extract1 and Coffea chloroform extract 2 | D. gallinae | Laboratory | M =25%1, and 100%2 | Intoxication* | [51] |
Neem Oil1, Assist2 | D. gallinae, O. sylviarum | Laboratory | M = 42.86%1, and 15% 2 | Intoxication | [86] |
Oil (individual) of bay, cade, cumin seed, ceylon cardamin, cedarwood, cinnamon, clove bud, clover leaf, coriander, eucalyptus, fir needle, ginger, horseradish, juniper berry, lavender, lemon 10, lemongrass, limedis 5F, mandarin orange, marjoram, mustard, oregano, palmarosa, pennyroyal, peppermint, pimento berry, rosemary, rosemary, peppermint, tea tree, thyme, haiti vetiver and absinthe | D. gallinae | Laboratory | M = 100% | Intoxication | [42] |
Basil1 oil or extract, java citronella2, clary sage3, geranium4, nutmeg5 and sage6 | D. gallinae | Laboratory | M = 56%1, 96%2, 92%3, 93%4, 51%5, and 89% 6 | Intoxication | [42] |
Neem oil | D. gallinae | Field | M = 92% | Intoxication | [48] |
Neem seed extract | D. gallinae | Field | M = 80% | Intoxication | [1] |
Eucalyptus essential oil: Eucalyptus citriodora1, E. staigeriana2, E. globulus3 and E. radiata4. | D. gallinae | Laboratory | M = 85%1,>65%2, 11%3, and 19% 4 | Intoxication | [31] |
2% liquid neem leaf extract + mineral oil + 0.1% degerming agent | O. sylviarum | Laboratory | M = > 50% | Intoxication | [90] |
Thyme oil | D. gallinae | Laboratory | M = 50% | Intoxication | [29] |
Lavender oil1, thyme oil 2, oregano oil3, juniper oil4 | D. gallinae | Laboratory | M =>97%1, 84%2, 50%3, and 50%4 | Intoxication | [67] |
Acerola cherry oil (individual), bergamot peel, caraway, cinnamon bark, cinnamon leaf, java citronella, clary sage, clove bud, garlic, gurjan balm, hyssop, lavender, lemon peel, lemongrass, lime, marjoram, mint avensis, mustard, onion, pennyroyal, peppermint, pine, rosemary, white thyme | D. gallinae | Laboratory | M = 100% | Intoxication | [43] |
Cedarwood oil1, redhead oil 2, grapefruit oil3, lemon oil4, peanut 5 oil, sandalwood oil6 | D. gallinae | Laboratory | M = 48.9%1, 42;2%2, 8;9%3, 33.3%4, 8.9% 5, and 20%6 | Intoxication | [43] |
Clove bud and leaf oil1, steamed lychee oil2, hemp essential oil3 | D. gallinae | Laboratory | M = 100%1, 80%2, and 79.26%3 | Intoxication | [96] |
Diatomaceous earth 10%1, Diatomaceous earth 10% + mechanical cleaning2 | D. gallinae | Laboratory | M = 93.4%1, and 90%2 | Intoxication and paralysis | [3] |
Ajowan essential oil and ajowan alcoholic extract | D. gallinae | Laboratory | >90% | Intoxication | [4] |
Product | Mite | Test environment | Mortality* | Reference |
---|---|---|---|---|
Entomopathogenic fungi: Beauveria bassiana1 and Metarhizium anisopliae2 | D. gallinae | Laboratory | 78%1, and 44%2 | [40] |
Solution of entomopathogenic fungi: Beauveria bassiana + Metarhizium anisopliae | D. gallinae | Field | 61.7% | [40] |
Fungus Trap: Trichoderma album | D. gallinae | Field and laboratory | 100% | [65] |
Fungus Trap: Beauveria bassiana | D. gallinae | Field1 andlaboratory2 | 80%1, and 100%2 | [65] |
Formulated with entomopathogenic fungi: Beauveria bassiana | D. gallinae | Laboratory | 98% | [53] |
Entomopathogenic fungus: Aspergillus oryzae | D. gallinae | Laboratory | 24.83% | [108] |
Antigen | Presentation | IgY levels* | Feeding challenge/model | Efficiency/mortality | Action | Reference |
---|---|---|---|---|---|---|
DGE | Brute | ↑ (p ≤ 0.05) | in vitro/laboratory | 50.60% | Tissue paralysis | [33] |
Bm86 | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 23.03% | Interference with the digestive system | [32] |
Subolesin | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 35.10% | Interference in the expression of gene regulation of transcription | [32] |
Tropomyosin D. gallinae (Der g 10) | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 19% | Interference with muscle movement and structural integrity of tissue | [109] |
Paramyosin (Der g 11) | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 23% | interference with muscle movement and structural integrity of tissue | [109] |
SME | Brute | ↑ (p ≤ 0.05) | in vitro/laboratory | 78.00% | − | [5] |
(Deg-VIT-1) +(Deg-SRP-1) +(Deg-PUF -1) | Recombinant | ↑ (p ≤ 0.05) | In vivo/Field | 0% | − | [5] |
PRM | Brute | ↑ (p ≤ 0.05) | in vitro/laboratory | 58.30% | − | [5] |
Deg-AKR | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 42%* | − | [45] |
CatD-1 in Montanide™ ISA 71 VG adjuvant | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 50%* | − | [76] |
Dg-CatD-1 DNA | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 0% | − | [76] |
Dg-CatD-1 E. tenella | Transgenic | ↑ (p ≤ 0.05) | in vitro/laboratory | 0% | − | [76] |
rDg-CatD-1 (Cathepsin D, CatD) | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 63.40% | Interference in the digestive process | [111] |
rDg-CatL-1(Cathepsin L, CatL) | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 48.01% | Interference in the digestive process | [111] |
rDg-Lgm (legumain, Lgm) | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 18.37% | Interference in the digestive process | [111] |
Dg-APMAP | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | 61.88% | Plasma membrane interference | [27] |
Deg-CPR-1 | Recombinant | ↑ (p ≤ 0.05) | in vitro/laboratory | >50% | Interference in the digestive process | [60] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 MDPI (Basel, Switzerland) unless otherwise stated